HomeATOS • NASDAQ
add
Atossa Therapeutics Inc
Previous close
$1.45
Day range
$1.44 - $1.46
Year range
$0.62 - $2.30
Market cap
182.35M USD
Avg Volume
530.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.10M | -8.83% |
Net income | -6.05M | 38.46% |
Net profit margin | — | — |
Earnings per share | -0.05 | 37.50% |
EBITDA | -7.10M | 8.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 79.53M | -19.99% |
Total assets | 85.86M | -20.76% |
Total liabilities | 5.70M | 63.77% |
Total equity | 80.16M | — |
Shares outstanding | 125.76M | — |
Price to book | 2.27 | — |
Return on assets | -20.08% | — |
Return on capital | -21.41% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -6.05M | 38.46% |
Cash from operations | -4.53M | -1.48% |
Cash from investing | -3.00K | 76.92% |
Cash from financing | 100.00K | — |
Net change in cash | -4.43M | 0.98% |
Free cash flow | -2.82M | -19.57% |
About
Founded
2008
Headquarters
Website
Employees
12